Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 4, 2008, Pages 437-440

  Bennett, Jason W ^a   Murray, Clinton K ^a   Holmes, Robert L ^b   Patterson, Jan E ^c   Jorgensen, James H ^d  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bactericidal effect; Daptomycin resistance; Minimum inhibitory concentration; MRSA bacteremia; Vancomycin tolerance

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOOD CULTURE; BROTH DILUTION; CASE REPORT; DEMENTIA; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TOLERANCE; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HUMAN; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; URINARY TRACT INFECTION;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; FEMALE; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 40749137361     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.11.002     Document Type: Article

References (22)

1. Bradley J.J., Mayhall C.G., and Dalton H.P. Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 13 (1978) 1052-1057
2. Clinical and Laboratory Standards Institute. Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline M26-A (1999), Clinical and Laboratory Standards Institute, Wayne, PA
3. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A7 (2006), Clinical and Laboratory Standards Institute, Wayne, PA
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement M100-S16 (2006), Clinical and Laboratory Standards Institute, Wayne, PA
5. Cui L., Tominaga E., Neoh H., and Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 1079-1082
6. Denny A.E., Peterson L.R., Gerding D.N., and Hall W.H. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch. Intern. Med. 139 (1979) 1026-1031
7. Gilmore M.S., and Hoch J.A. Antibiotic resistance. A vancomycin surprise. Nature 399 (1999) 524-527
8. Hayden M.K., Rezai K., Hayes R.A., Lolans K., Quinn J.P., and Weinstein R.A. Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43 (2005) 5285-5287
9. Marty F., Yeh W.W., Wennersten C., Wennersten C.B., Venkataraman L., Albano E., Alyea E.P., Gold H.S., Baden L.R., and Pillai S.K. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J. Clin. Microbiol. 44 (2006) 595-597
10. May J., Shannon K., King A., and French G. Glycopeptide tolerance in Staphylococcus aureus. J. Antimicrob. Chemother. 42 (1998) 189-197
11. McDonald L.C. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin. Infect. Dis. 42 (2006) S65-S71
12. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., and Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41 (2003) 5113-5120
13. Moise P.A., Sakoulas G., Forrest A., and Schentag J.J. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 51 (2007) 2582-2586
14. Mwangi M.M., Shang W.W., Yanjiao Z., Krzysztof S., Herminia de Lencastre, Richardson P., Bruce D., Rubin E., Myers E., Siggia E.D., and Tomasz A. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 9451-9456
15. Norden C.W., and Keleti E. Antibiotic tolerance in strains of Staphylococcus aureus. J. Antimicrob. Chemother. 7 (1981) 599-605
16. Perry J.D., Jones A.L., and Gould F.K. Glycopeptide tolerance in bacteria causing endocarditis. J. Antimicrob. Chemother. 44 (1999) 121-124
17. Rajashekaraiah K.R., Rice T., Rao V.S., Marsh D., Ramakrishna B., and Kallick C.A. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann. Intern. Med. 93 (1980) 796-801
18. Sader H.S., Fritsche T.R., and Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50 (2006) 2330-2336
19. Safdar A., and Rolston K.V.I. Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer. Cancer 106 (2006) 1815-1820
20. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering Jr. R.C., and Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42 (2004) 2398-2402
21. Sakoulas G., Alder J., Thauvin-Eliopoulos C., Moellering Jr. R.C., and Eliopoulos G.M. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob. Agents Chemother. 50 (2006) 1581-1585
22. Sieradzki K., and Tomasz A. Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus. Antimicrob. Agents Chemother. 50 (2006) 527-533